baber/WOPTO huggingface dataset:
Patent IL-68612-A0 (IL)
Title: 2-aryltetraazaindenes
IPC: A61P43/00
Filed: 1983-05-06
Abstract: 2-Aryltetraazaindenes of the formula   <IMAGE>   wherein -A- is -N=CH-CN=N- or -CH=N-N=CH-, Ar is unsubstituted phenyl or phenyl mono-, di- or tri-substituted by hydroxyl, mercapto, dialkylamino, trifluoromethyl and/or -Z-R groups, Z is -O-, -S- or -SO- and R is alkyl, alkenyl, alkynyl or cyanomethyl, the alkyl, alkenyl and alkynyl groups each having up to 5 C atoms, and their physiologically acceptable salts, exhibit blood pressure, myocardial contraction, and anti-ulcer activities.
Patent IL-75116-A0 (IL)
Title: Beta-carboline-3-carboxylic acid derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IPC: A61P25/20
Filed: 1985-05-07
Abstract: New  beta -carboline-3-carboxylic acid esters having the general formula I: <CHEM>  wherein R<4>, R<5> and R<6> have specified meanings. The new compounds which exhibit surprising psychotropic properties are prepared by an analogy method.
Patent IL-83358-A0 (IL)
Title: Nickel alloy anodes for electrochemical dechlorination
IPC: C22C19/05
Filed: 1987-07-28
Abstract: Nickel alloy anodes are suitable for electrochemical cells that are used for the selective replacement of chlorine in organochlorine compounds with hydrogen and are resistant to corrosion. Electrochemical cells containing Hastalloy C-276 anodes and silver cathodes, for example, are used to convert tetrachloropicolinic acid to 3,6-dichloropicolinic acid.
Patent IL-86246-A0 (IL)
Title: Intercellular adhesion molecules and functional derivatives thereof,their production and antibodies against thereto
IPC: G01N33/53
Filed: 1988-05-03
Abstract: The present invention relates to intercellular adhesion molecules (ICAM-1) which are involved in the process through which lymphocytes recognize and migrate to sites of inflammation as well as attach to cellular substrates during inflammation. The invention is directed toward such molecules, screening assays for identifying such molecules and antibodies capable of binding such molecules. The invention also includes uses for adhesion molecules and for the antibodies that are capable of binding them.
Patent IL-87433-A0 (IL)
Title: Condensed diazepinones,their preparation and pharmaceutical compositions containing them
IPC: C07D471/04
Filed: 1988-08-12
Abstract: Condensed diazepinones of the general formula I <IMAGE>  in which <IMAGE> represents one of the divalent radicals <IMAGE> and X<1>, X<2>, A, R<1> to R<1><0> and Z have the following meanings: X<1> and X<2> represent a = CH-group or, if <IMAGE> assumes the meanings of the abovementioned divalent radicals (S), (U) or (W), both or only X<1> or only X<2> can also represent a nitrogen atom; A is an alkylene radical having two to seven carbon atoms; which can also be interrupted by an oxygen or sulphur atom or by the methylimino or ethylimino group; Z is a single bond, an oxygen or sulphur atom, the methylene or 1,2-ethylene group; R<1> is a lower alkyl radical or the benzyl group; R<2> is an alkyl radical having 1 to 7 carbon atoms, which can optionally be further substituted by a hydroxyl group on its 2nd to 7th carbon atom, a cycloalkyl or a cycloalkylmethyl radical, where the cycloalkyl ring can optionally be further substituted by a hydroxyl group; R<1> and R<2>, however, together with the nitrogen atom lying in between, can also form a 4- to 7-membered saturated, monocyclic heterocyclic ring which can optionally be interrupted by an oxygen atom or by the N-CH3 group; R<2> can, however, also be linked to A via an alkylene bridge such that, together with the group NR<1>, a saturated, 5 to 7-membered heterocyclic ring system is formed; R<3> is a lower alkyl group, a chlorine atom or a hydrogen atom; R<4> is a hydrogen atom or a methyl group; R<5> and R<6> each denote a hydrogen atom, a fluorine, chlorine or bromine atom or a lower alkyl group; R<7> is a hydrogen or chlorine atom or a methyl group; R<8> is a hydrogen atom or a lower alkyl radical; R<9> is a hydrogen or halogen atom or a lower alkyl group and R<1><0> is a hydrogen atom or a methyl group, where in the case in which <IMAGE> represents the divalent radical (T) and R<7> is hydrogen, R<3> cannot be chlorine and Z cannot be sulphur. Processes for their preparation and medicaments which contain these compounds are also described. In view of the lack of gastric acid secretion-inhibiting, salivation-inhibiting and mydriatic influences, the novel diazepinones are suitable as vagal pacemakers for the treatment of bradycardias and bradyarrhythmias in human and veterinary medicine.
Patent FI-20012210-A0 (FI)
Inventor: JAHKONEN PEKKA
IPC: H02P3/22
Filed: 2001-11-14
Abstract: The invention relates to an electric motor drive for operating an alternating-current motor. The electric motor drive comprises a frequency converter for controlling the motor, which frequency converter comprises a rectifier and an inverter implemented using semiconductor switches arranged in a bridge, and an intermediate circuit placed between the rectifier and the inverter and comprising a capacitor. According to the invention, the electric motor drive additionally comprises two regulating units, the first one of which contains an inductor unit provided at the input of the frequency converter and at the same time at the input of the rectifier, the inductors comprised in the unit being connected to each phase; and an intermediate circuit with a low-value capacitor, of the order of 50 muF, while the second one contains an auxiliary switch, to which the supply of electric power is arranged to occur via a safety relay, the auxiliary switch being so connected to selected semiconductor switches of the inverter bridge that the control signal for a selected semiconductor switch will pass via the auxiliary switch when the latter is in a conducting state; and a current measuring unit for measuring and/or monitoring the supply current to the electric motor.
Patent FI-20050304-A0 (FI)
Inventor: HIETALA JONI
IPC: F21V8/00
Filed: 2005-03-21
Abstract: An illumination system, a method for illuminating an illumination object(100, 100') and an electronic device comprising the illumination system. The illumination system comprises an illumination object (100, 100'), a light-emitting unit (106) and a discrete light channel (108) which is operationally connected to the light-emitting unit (106) and the illumination object (100,100') and which is arranged to transfer emitted light from the light source (106) to the illumination object(100, 100').
Patent FI-20090035-A0 (FI)
Inventor: RAJALA JUHANI
IPC: A01G/
Filed: 2009-02-04
Abstract: Greenhouse plants are illuminated with illuminators that are arranged on brackets of illuminator units. The illuminator units are in turn hung on a guide or guides arranged above the plants. To enable maintenance and harvesting work, each bracket with its illuminators is movable upward.
Patent FI-20106107-A0 (FI)
Inventor: PAASONEN JAN
IPC: F16C/
Filed: 2010-10-26
Abstract: The method involves applying the polymer material on the surface of fiber web machine-roller (10) by using a material supply element (204), under simultaneous rotation of the roller around own axis. The circumferential speed of an epoxy covering is matched with respect to the polymer material feeding speed. The composition of epoxy covering is converted into a non-flowable form during the rotation process of roller. The position of the material supply element is changed towards the rolling longitudinal axis (12). An independent claim is included for fiber web machine-roller.
Patent FI-20115447-A0 (FI)
Inventor: LAMPINEN MARKKU
IPC: F23R/
Filed: 2011-05-10
Abstract: The present invention relates to a combustion method, wherein a burner is used, which contains one or more tubular, semi-permeable burner membranes laid parallel, whereby the fuel is introduced into the combustion space formed of the membranes, and both the oxygen and the nitrogen of the combustion air, in ionized form, are transported through the membrane into the combustion space without the assistance of a compressor, whereby the fuel is reacted with the oxygen of the combustion air. The present invention also relates to such a burner containing one or more tubular semi-permeable membranes.
Patent IL-101024-A0 (IL)
Title: Process for the activation of recombinant proteins
IPC: C07K14/535
Filed: 1992-02-20
Abstract: A method for activating recombinant proteins which are in an at least partially inactive form, in which solubilisation and/or renaturation techniques known per se are used to activate a protein which contains at its N and/or C terminus additional helper sequences with a length of 2 to 50 amino acids, where the relative hydrophobicities of these helper sequences, calculated as the total of the relative hydrophobicities, indicated in Table 1, of the individual amino acids, have a negative numerical value. <IMAGE>
Patent IL-108623-A0 (IL)
Title: Silylated acetylcholinesterase inhibitors
IPC: A61P25/28
Filed: 1994-02-11
Abstract: Fluorinated silylated aromatic compounds possessing anticholinesterase activity and methods of treating Degenerative Dementias using these compounds.
Patent IL-112116-A0 (IL)
Title: Vinylcarboxylic acid derivatives
Inventor: MAIENFISCH PETER
IPC: A01N41/06
Filed: 1994-12-22
Abstract: Compounds of the formula <CHEM>  wherein   R1   is C3-C8cycloalkyl, halo-C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C6alkyl, halo-C3-C8cycloalkyl-C1-C6alkyl, -Si(R3)3, -S-R4, -SO2-R6 or -CO-R9; R2   is halogen, C1-C4alkyl or CF3, the substituents R2 being identical or different when n is 2; R3   each independently of the others is C1-C6alkyl, haloC1-C6alkyl, C1-C6alkoxy or phenyl; R4   is aryl or heteroaryl each of which is unsubstituted or substituted; R6   is unsubstituted or substituted C1-C10alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C20alkoxy, C2-C6alkenyloxy, C2-C6alkynyloxy, C1-C4alkylthio, aryl, aryloxy or arylthio, or is optionally substituted amino; R9   is hydroxy, unsubstituted or substituted C1-C10alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C8cycloalkyl, aryl or aryloxy, or is optionally substituted amino; R12   is hydrogen or unsubstituted or substituted C1-C10-alkyl; m   is 1, 3, 5, 7, 9 or 11; n   is 0, 1 or 2; X   is fluorine or chlorine; and Y   is hydrogen, fluorine or methyl; in free form or in salt form, can be used as pesticides and can be prepared in a manner known per se.
Patent IL-117425-A0 (IL)
Title: Receptor activation by gas6
IPC: C12R1/91
Filed: 1996-03-10
Abstract: The translation product of the growth arrest-specific gene 6 (gas6) has been identified as an activator of the Mer receptor protein tyrosine kinase. The invention accordingly provides methods of activating Mer receptor in cells expressing it by exposing them to exogenous gas6 polypeptides. Also provided are methods of enhancing the growth, differentiation, or survival of such cells using gas6 polypeptides.
Patent IL-118603-A0 (IL)
Title: Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
IPC: C08B37/00
Filed: 1996-06-07
Abstract: The process for depolymerizing Group B Types II and III Streptococcal Polysaccharide is disclosed which results in polysaccharide fragments having a reducing end suitable for conjugating to protein. Conjugate molecules, vaccines and their use to immunize mammals including humans are also disclosed.
Patent IL-131714-A0 (IL)
Title: Plant for desalination or purification of sea or brackish water by means of solar energy
IPC: C02F1/04
Filed: 1998-03-10
Abstract: PCT No. PCT/AT98/00061 Sec. 371 Date Sep. 10, 1999 Sec. 102(e) Date Sep. 10, 1999 PCT Filed Mar. 10, 1998 PCT Pub. No. WO98/40313 PCT Pub. Date Sep. 17, 1998A facility for the desalination and purification of sea water or brackish water by solar energy provided with a closed cycle including a thermal solar collector and a heat exchanger in which a heat transfer medium is circulating, and a basin for receiving the sea water or brackish water with the heat exchanger being placed in the basin for heating and evaporating water. A cooling surface is disposed above the basing for condensing the evaporated water which is then diverted to water collectors. The solar collector is located above the cooling surface so as to keep it in the shade.
Patent IL-133258-A0 (IL)
Title: Method and apparatus for producing cement clinker
IPC: F27B15/00
Filed: 1998-01-13
Abstract: The invention relates to the production of cement clinker from powdered and fine-grained raw material using a cyclone preheater, a precalcination arrangement, a kiln and a cooler. In order that fine dust filtered out of the exhaust gases from the preheater can also be reliably preheated, precalcined and then burn to cement clinker in a kiln, after the first preheater stage a smaller part-quantity of the material is branched off and fed jointly with the total fine dust from the filter to the upper end of the precalcination arrangement, and this material mixture passes through the precalcination arrangement from top to bottom, is guided in co-current with air for combustion and, with fuel being delivered, is thereby precalcined and then introduced into the kiln inlet.
Patent IL-134534-A0 (IL)
Title: Process for the recycle of a waste product of diltiazem synthesis
IPC: C07C323/62
Filed: 1998-10-12
Abstract: A process which allows the re-use of compounds of formula in diltiazem synthesis through a process of conversion to a mixture of enantiomers III-(2R,3R) and III-(2S,3S) is described.
Patent IL-144028-A0 (IL)
Title: Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
IPC: A61P31/22
Filed: 2000-01-07
Abstract: Immune response modifier (IRM) compounds-imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo- and oxazolo-quinolinamines and pyridinamines, imidazonaphthyridine and tetrahydroimidazonaphthyridine amines-are useful for the treatment of conditions at and below the mucosal surfaces by administering a therapeutically effective amount of such compounds to the mucosal surface. Novel pharmaceutical formulations are provided. In one embodiment, the pharmaceutical formulations are advantageous for treatment of cervical conditions such as cervical dysplasias including cervical intraepithelial neoplasias.
Patent IL-160908-A0 (IL)
Title: Method for determining cell cycle position
IPC: C07K14/47
Filed: 2002-09-12
Abstract: The invention provides a novel, non-destructive and dynamic process for determining the cell cycle position of living cells. The invention also provides DNA constructs, and cell lines containing such constructs, that exhibit activation and deactivation of a detectable reporter molecule in a cell cycle specific manner. The invention thus allows greater precision in determining cell cycle phase status than existing techniques and further provides a method for continuous monitoring of cell cycle progression in individual cells.
Patent IL-169273-A0 (IL)
Title: Corrugated cardboard crib
IPC: A47D9/00
Filed: 2005-06-19
Abstract: Disclosed is a baby crib or cradle constructed from foldable material, preferably corrugated cardboard that forms multiple elements from a single sheet of material, and supports the baby above the ground. In kit form, the crib may be supplied in a partially assembled state to facilitate ease of end user assembly.
Patent IL-174931-A0 (IL)
Title: A lipid preparation for enhancing mineral absorption
IPC: A23D7/00
Filed: 2006-04-11
Abstract: The invention provides an enzymatically-prepared fat base composition which comprises a mixture of vegetable-derived triglycerides. The fat base composition has a total palmitic acid residues content of at most 38% of the total fatty acid residues, and at least 60%, preferably 62% of the fatty acid moieties at the sn-2 position of the glycerol backbone are palmitic acid residues, at least 70% of the fatty acid moieties at the sn-1 and sn-3 positions of the glycerol backbone are unsaturated, at least 40%, preferably 40-60%, of the unsaturated fatty acid moieties at the sn-1 and sn-3 positions are oleic acid moieties, and at least 6%, preferably 6-17%, of the unsaturated fatty acid moieties at the sn-1 and sn-3 positions are linoleic acid moieties. The invention also provides preparation and various uses of the fat base composition in the field of infant nutrition.
Patent IL-188232-A0 (IL)
Title: Electric connector assembly having a device for protection against pollution
Filed: 2007-12-18
Abstract: The assembly has a flat cover shaped flap (30) with a joint (38), pivoted between a closed position in which the flap blocks an access to hollow tubular shaped secondary contacts (24) co-operated with primary contacts (20), and an open position in which the flap permits the access for connecting a plug (10) on a base. An annular sleeve (40) is fixed to an electrical cable/lead (14) and displaced between extreme positions such as lowered position in which the sleeve covers the flap when the plug and the base are connected, and raised position in which the sleeve permits an access to the plug.
Patent RO-125400-A0 (RO)
Title: System for orientation according to sun
Inventor: CERNOMAZU DOREL
IPC: F24S50/20
Filed: 2009-01-23
Abstract: The invention relates to a system for orientation of a solar collector according to the sun. According to the invention, the system for orientation according to the sun, consists mainly of two motors (M1 and M2) with flexible rotor and axial air gap meant to actuate a solar collector following the two axes defining the azimuthal orientation system, the motors (M1 and M2) being supplied with a succession of impulses provided by a direct current source controlled by means of a computer ( C).
Patent RO-129437-A0 (RO)
Title: Process for obtaining hollow metallic micro particles
Inventor: BAC REA VLADIMIR-CONSTANTIN
IPC: B01J8/00
Filed: 2013-12-09
Abstract: The invention relates to a process for obtaining hollow metallic micro particles which, due to their reduced density and high specific surface, have a multitude of applications in the preparation of electrically- and thermally-conductive paints and pastes, coatings for protection against electromagnetic fields, powders for producing light pieces by powder metallurgy, moulding paste for making low-cost jewelry, micro containers for biologically active substances, catalysts, chromatographic fillers and the like. According to the invention, the process employs an aqueous suspension of unicellular microorganisms such as yeasts or bacteria or other unicellular biogenous formations, such as erythrocytes, pollen or spores, which are treated, in the first stage, while stirring, at solar or ultraviolet light, at the ambient temperature and pressure and a neutral pH ranging between 4.5...8.5, with a metal compound for surface activation by forming nucleation germs on the cellular membrane, these being intended to catalyze the subsequent deposition and the growth of the metal layer by the reduction of a metallic compound within the solution with a suitable reducing agent, separation of the metallized micro particles by filtration and washing, followed by removal of the biogenous core by alkaline hydrolysis, namely by refluxing for 4...6 h with an aqueous solution of 2...25% NaOH and repeatedly washing with water and organic solvents up to a neutral pH value or by mixing, in a wet phase, with a 2...4 times higher amount of sodium carbonate as powder, followed by drying and calcination of the resulting paste at a temperature of 400...650°C, washing with water up to a neutral pH and drying.
Patent RO-130852-A0 (RO)
Title: Production and use of customized hyperimmune egg () for emergency treatment of patients infected with pathogenic germs
Inventor: PĂTRAŞCU IONEL VICTOR
IPC: C07K16/02
Filed: 2015-09-03
Abstract: The invention relates to a method for preparing an immunologic product and to the use thereof for treating patients infected with pathogenic germs. According to the invention, the method comprises the quick immunization of conventional hens aged over 24 weeks with the antigen resulting from the pathologic material taken from sick patients, in admixture with an adjuvant QS21, the antigenic mass being administered intramuscularly to the hens 3 times at an interval of 14 days, concomitantly with an immunomodulator P, which is administered orally, in admixture with the fodder, after which the eggs of immunized hens are collected 14 days after the third innoculation and specific immunoglobulins are extracted therefrom. The product is used in conditioned form, in the patients from whom the pathologic material was taken.
Patent AP-2001002103-A0 (AP)
Title: Substituted phenyl derivatives, their preparation and use.
Inventor: DAHL BJARNE H
IPC: A61K31/4439
Filed: 1999-10-19
Abstract: The prevent invention discloses compounds having formula (i)wherein the substituents are defined in the application. The compounds are useful as chloride channel blockers.
Patent ZM-482-A1 (ZM)
Title: Imidazodiazepines
IPC: C07D487/04
Filed: 1982-01-28
Abstract: There is provided imidazodiazepines of the formula    <IMAGE>  1 wherein A together with the two carbon atoms denoted as  alpha  and beta  is the group   <IMAGE>   X is an oxygen or sulphur atom and R1 is hydrogen or lower alkyl, and either R2 is hydrogen, trifluoromethyl, halogen, cyano or nitro and R3 is hydrogen or R2 is hydrogen and R3 is trifluoromethyl, halogen, cyano, nitro or lower alkyl, and their pharmaceutically acceptable acid addition salts. The compounds are useful in the antagonization of the central-depressant, muscle relaxant, ataxic, blood pressure-lowering and respiratory-depressant properties of 1,4-benzodiazepines which have tranquillizing activity, for example as antidotes in the case of intoxications with 1,4-benzodiazepines which have tranquillizing activity. Also presented are methods to produce the above imidazodiazepines.
Patent IE-910070-A1 (IE)
Title: Circular dichroism and spectrophotometric absorption¹detection methods and apparatus
IPC: G01N33/74
Filed: 1991-01-10
Abstract: Spectrophotometric methods, including the use of convention spectroscopic absorption or circular dichroism, for clinical chemistry detection methods. More specifically, with the use of such spectrophotometric methods in the measurement of cholesterol levels and direct measurement of cholesterol subfractions in clinical samples, and in the measurement of lipoprotein levels in a clinical test sample, as well as in the detection of anabolic steroids and other steroid products. The invention is also concerned with providing certain CD and conventional spectrophotometric apparatus useful in each of the aforesaid chemical methods.
Patent MC-2056-A1 (MC)
Inventor: FERENC HORVATH
IPC: A61P17/00
Filed: 1987-12-23
Abstract: PCT No. PCT/HU87/00060 Sec. 371 Date Sep. 15, 1989 Sec. 102(e) Date Sep. 15, 1989 PCT Filed Dec. 23, 1987 PCT Pub. No. WO89/05651 PCT Pub. Date Jun. 29, 1989.The invention relates to therapeutical compositions on medical herb basis for the treatment of psoriasis and the preparation of the same. A further object of the invention in the use of medical herbs as listed below in the treatment of psoriasis, rheumatism and asthmatic dyspnoea. The medical herbs used in the invention are as follows: Allium sativum /garlic/, Urtica dioica /common nettle/, Chelidonium majus /milkweed/, Veronica officinalis /veronica/, Calendula officinalis /calendula or marigold/, Achillea herba /millefolium/ /yarrow/, Fumaria officinalis /fumitory, earth-gall/.
Patent IE-910305-A1 (IE)
Title: Compositions with enhanced penetration
Inventor: MAHJOUR MAJID
IPC: A61K9/00
Filed: 1991-01-29
Abstract: The invention comprises a two-ply composite laminate for transmembranal administration of an active medicament consisting of   A.) a layer I comprising a component A consisting of a solvent and an active medicament incorporated in a partly cured elastomer, B.) a layer II laminated onto layer I comprising a component B consisting of a solvent and an active medicament e.g. THA (tacrine) incorporated in a macroporous slab with a pore size of 10 to 100  mu m. h